| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.4 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.4 |